J&J Talks Pharmaceuticals With Investors

In an effort to capitalize on the booming pharmaceutical market, which is expected to grow to more than $1 trillion by 2015, Johnson & Johnson (JNJ) said it will review growth strategies for its pharmaceuticals business at a meeting with investors on Thursday. Senior leaders from the company's executive committee and pharmaceuticals segment will review how the business plans to address unmet medical needs and outpace the market's growth by optimizing its product portfolio. “The health care industry is undergoing dramatic change and with science evolving rapidly, we are well-positioned for the new demands, requirements, demographics and trends shaping the health care market,” Sheri McCoy, vice chairman of the executive committee, said in a statement. Continue reading the article.